The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing medicine.
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Related Posts
Sarah Ferguson admits Prince William wedding brought bitter memories
Sarah Ferguson admits Prince William and Kate Middleton’s wedding in 2011 turned out to be a moment of reflection.The Duchess of York, who was married to Prince Andrew before splitting…
Boeing: Aviation giant makes 38% pay rise offer in bid to end strike
Getty ImagesStriking Boeing workers are set to vote on a new offer from the aviation giant, which includes a 38% pay rise over the next four years.The International Association of…